Subject: RE: link to resources
From: Ketevan Goginashvili
To: Shipra Srihari <[email-masked]>, "[email-masked]<[email-masked]>" <[email-masked]>, [email-masked]
Cc: Grace Chee <[email-masked]>, Tesfaye Dereje <[email-masked]>, Neha Acharya <[email-masked]>
Date: Tue, 08 Jan 2019 10:30:00 +0000

Dear Shipra,

Thank you for information and possibility to participate in webinar. It was very informative and useful for me.

With best regards, Keti

Ketevan Goginashvili, MPH

Head of Health Policy Division

Health Care Department

Ministry of Internally displaced Persons

from  Occupied Territories,

Labor, Health and Social Affairs

144 Tsereteli Ave

Tbilisi 0119, Georgia

Tel: +995 32 251 00 38 ext 1108

Mob: 995 577717984

From: Shipra Srihari [mailto:[email-masked]]
Sent: 07 January, 2019 22:54
To: Ketevan Goginashvili; [email-masked]
Cc: Grace Chee; Tesfaye Dereje; Neha Acharya
Subject: link to resources

Dear Keti and Landry,

I hope you received the follow-up email from Tesfaye that shared links for the various materials we’ve produced. Thanks again for your valuable participation and input!!

I just wanted to point you to the link for the podcast, which includes clips of both of you speaking in the webinar. Unfortunately, the quality of the recording of the webinar was not clear enough for the podcast, so we had to have our Communications staff speak your points. We prepared a transcript for them, which they then read out, to make sure that what they said was the same as what you did! You’ll hear your names and you’ll hear your voices as you start speaking, and then you’ll notice that someone else’s voice then continues with your speaking points.

http://podcasts.abtcapabilities.com/producing-and-using-immunization-expenditure-data.html

Thanks again, and please do reach out if you have any questions.

Kind regards,

Shipra

Shipra Srihari, PhD MPH | Associate

International Development Division | Abt Associates

O: 617.520.3919 | www.abtassociates.com

This message may contain privileged and confidential information intended solely for the addressee. Please do not read, disseminate or copy it unless you are the intended recipient. If this message has been received in error, we kindly ask that you notify the sender immediately by return email and delete all copies of the message from your system.